What are the benefits and functions of Carbidopa/Levodopa Sustained-Release Tablets?
Carbidopa and Levodopa Extended-Release Tablets are a compound preparation commonly used for the treatment of primary Parkinson's disease. They can play a certain role in alleviating the symptoms of patients. During medication, patients should be aware of the precautions for use and prevent any side effects caused by medication. Additionally, not everyone can use this medication for treatment, and individuals who are allergic to this drug should avoid using it. So what are the effects and functions of Carbidopa and Levodopa Extended-Release Tablets? Let's take a look at this aspect.
1. Effects and Functions of Carbidopa and Levodopa Extended-Release Tablets
The effects of Carbidopa and Levodopa Extended-Release Tablets are influenced by its composition. Carbidopa and Levodopa Extended-Release Tablets are a compound preparation containing 50mg of Carbidopa and 200mg of Levodopa. The components of the drug determine its effects, and the main function of Carbidopa and Levodopa Extended-Release Tablets is to treat primary Parkinson's disease, as well as Parkinson's syndrome caused by encephalitis, symptomatic Parkinson's syndrome, and Parkinson's disease or syndrome in patients taking vitamin preparations containing pyridoxine.
2. Precautions for Using Carbidopa and Levodopa Extended-Release Tablets
However, Carbidopa and Levodopa Extended-Release Tablets are not suitable for the following situations: patients using monoamine oxidase inhibitors must stop using them for at least 2 weeks before using this drug. Patients who are allergic to any component of this drug or have narrow-angle glaucoma, or have a history of suspected skin cancer or melanoma should avoid using it. Patients who need it can prescribe the medication based on their actual situation. Carbidopa and Levodopa Extended-Release Tablets are taken orally, and the dosage is determined based on the actual condition of the patient. It is recommended that patients consult a doctor before using Carbidopa and Levodopa Extended-Release Tablets.
3. Medication for Pregnant and Lactating Women
The effect of Carbidopa and Levodopa Extended-Release Tablets on human pregnancy is not yet clear, but the combination of Levodopa and Carbidopa can cause abnormal development of the internal organs and bones of rabbits. Therefore, pregnant women should use it with caution. It is not clear whether Carbidopa and Levodopa can be secreted in human milk, so the decision to stop breastfeeding or discontinue the drug should be based on the importance of the medication to the lactating mother.
